Declining incidence of AIDS and increasing prevalence of AIDS presenters among AIDS patients in Italy

被引:21
作者
Castelnuovo, B
Chiesa, E
Rusconi, S
Adorni, F
Bongiovanni, M
Melzi, S
Cicconi, P
Tordato, F
Meroni, L
Bini, T
Monforte, AD
机构
[1] Univ Milan, Inst Infect Dis & Trop Med, I-20157 Milan, Italy
[2] CNR, Inst Adv Biomed Technol ITBA, Milan, Italy
关键词
D O I
10.1007/s10096-003-1038-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Presented here are the results of a cohort study conducted on 3,483 consecutive HIV/AIDS patients between January 1993 and December 2000 to determine trends in AIDS incidence and presentation. The incidence of AIDS was calculated in the general population and examined further according to gender, age (less than or equal to or >49 years), and heterosexual behaviour as a risk factor for HIV. Multivariate analysis was used to identify variables associated with AIDS presenters (defined as patients diagnosed with AIDS within 1 month of the first HIV-positive test). The numbers of patients with AIDS classified as (i) AIDS presenters, (ii) known HIV-positive patients on antiretroviral treatment, and (iii) known HIV-positive patients not receiving antiretroviral treatment were calculated. The overall incidence of AIDS decreased over time, mainly due to the lower number of patients on antiretroviral treatment developing AIDS. Factors associated with a higher risk of being an AIDS presenter were male gender and year of HIV diagnosis. Among patients with AIDS, the proportion of AIDS presenters increased from 13.8% prior to 1997 (when protease inhibitors were introduced in Italy) to 32.5% after 1997. Variables predictive of being an AIDS presenter were male gender, age at diagnosis, and AIDS diagnosis in the years 1997-2000. Heterosexuals had a higher risk of being AIDS presenters and a lower risk of being HIV-positive and not receiving antiretroviral treatment than intravenous drug users. In Italy, AIDS occurs mainly in subjects unaware of their HIV status (especially males, the elderly, and those infected heterosexually) or in patients refusing antiretroviral therapy (mainly intravenous drug users who do not refer to specialised centres).
引用
收藏
页码:663 / 669
页数:7
相关论文
共 22 条
[11]   Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres [J].
Mouton, Y ;
Alfandari, S ;
Valette, M ;
Cartier, F ;
Dellamonica, P ;
Humbert, G ;
Lang, JM ;
Massip, P ;
Mechali, D ;
Leclercq, P ;
Modai, J ;
Portier, H .
AIDS, 1997, 11 (12) :F101-F105
[12]   Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS [J].
OBrien, WA ;
Hartigan, PM ;
Martin, D ;
Esinhart, J ;
Hill, A ;
Benoit, S ;
Rubin, M ;
Lahart, C ;
Wray, N ;
Finegold, SM ;
George, WL ;
Dickinson, GM ;
Klimas, N ;
Diamond, G ;
ZollaPazner, SB ;
Jensen, PC ;
Hawkes, C ;
Oster, C ;
Gordin, F ;
Labriola, AM ;
Spivey, P ;
Matthews, T ;
Weinhold, K ;
Drusano, G ;
Egorin, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (07) :426-431
[13]   Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J].
Palella, FJ ;
Delaney, KM ;
Moorman, AC ;
Loveless, MO ;
Fuhrer, J ;
Satten, GA ;
Aschman, DJ ;
Holmberg, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :853-860
[14]   FACTORS ASSOCIATED WITH LACK OF AWARENESS OF HIV-INFECTION BEFORE DIAGNOSIS OF AIDS [J].
PORTER, K ;
WALL, PG ;
EVANS, BG .
BRITISH MEDICAL JOURNAL, 1993, 307 (6895) :20-23
[15]   HIV-POSITIVE PATIENTS FIRST PRESENTING WITH AN AIDS-DEFINING ILLNESS - CHARACTERISTICS AND SURVIVAL [J].
POZNANSKY, MC ;
COKER, R ;
SKINNER, C ;
HILL, A ;
BAILEY, S ;
WHITAKER, L ;
RENTON, A ;
WEBER, J .
BRITISH MEDICAL JOURNAL, 1995, 311 (6998) :156-158
[16]   Temporal trends in reasons for and result of HIV-testing among women in Rome, Italy [J].
Puro, V ;
D'Ubaldo, C ;
Aloisi, NS ;
Sherr, L ;
Ippolito, G .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1998, 14 (05) :433-437
[17]   DECLINING PREVALENCE OF HIV-INFECTION AMONG INJECTING DRUG-USERS ENTERING DRUG-TREATMENT IN ITALY - 1990-1991 [J].
REZZA, G ;
DEROSE, A ;
DORRUCCI, M ;
ARPINO, C ;
SERAFIN, I .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1993, 9 (06) :663-666
[18]   Understanding delay to medical care for HIV infection: the long-term non-presenter [J].
Samet, JH ;
Freedberg, KA ;
Savetsky, JB ;
Sullivan, LM ;
Stein, MD .
AIDS, 2001, 15 (01) :77-85
[19]   Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults [J].
Staszewski, S ;
Morales-Ramirez, J ;
Tashima, KT ;
Rachlis, A ;
Skiest, D ;
Stanford, J ;
Stryker, R ;
Johnson, P ;
Labriola, DF ;
Farina, D ;
Manion, DJ ;
Ruiz, NM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1865-1873
[20]  
*USPHS IDSA, 2001, HIV CLIN TRIALS, V2, P493